CLL Navigator™: A Digital Community for People Living with CLL
May 2026

BeOne Medicines launches CLL Navigator™, a new digital community platform to support people living with chronic lymphocytic leukemia (CLL) and their caregivers by providing trusted education and tools. Learn more below.
Introducing CLL Navigator™, a digital community platform designed to support people living with chronic lymphocytic leukemia (CLL), and their loved ones, by providing them with trusted education, practical tools, and access to others in the CLL community.
CLL Navigator™ addresses critical friction points that people with CLL can experience, from initial diagnosis through long-term disease management, by providing clear, credible information in an increasingly complex, often-fragmented, and sometimes-inaccurate information landscape. Developed in collaboration with the CLL community and designed for continuous evolution, the platform is meant to mirror how people seek information today: in an ongoing, personalized way beyond traditional clinical settings.
CLL Navigator™ offers a wide variety of resources, including:
- Disease and clinical trial education
- Tools for engaging with doctors in shared decision-making
- Guidance on mental health and financial considerations for both people with CLL and caregivers
CLL Navigator™ features:
- Stories and insights from the CLL community
- Email and SMS support
- Connection to established external organizations and communities to enable access to additional support
As treatment advances continue to extend survival in CLL, the need for longitudinal, patient-centered support is increasing. Platforms like CLL Navigator™ aim to enhance patient understanding, engagement, and confidence to support more informed care interactions and help people with CLL and their caregivers navigate the complexities of living with CLL.